Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urologic Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07106762
What this trial is testing

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Who this might be right for
Urothelial Cancer
Bristol-Myers Squibb 470
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Not applicableStudy completedNCT01827254
What this trial is testing

Sutent Rechallenge In mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 61
Not applicableStudy completedNCT05970471
What this trial is testing

Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital

Who this might be right for
Preference, PatientPharmacist-Patient RelationsCaregiver+1 more
Centre Hospitalier Universitaire de Besancon 167
Testing effectiveness (Phase 2)Study completedNCT02853344
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 275
Not applicableLooking for participantsNCT06170177
What this trial is testing

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Who this might be right for
Muscle-Invasive Bladder CarcinomaMuscle Invasive Bladder Urothelial CarcinomaBladder Cancer TNM Staging+14 more
IRCCS San Raffaele 4,000
Post-approval studies (Phase 4)Looking for participantsNCT06903312
What this trial is testing

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Who this might be right for
Renal Cell CancerKidney NeoplasmImmunotherapy+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 409
Not applicableStudy completedNCT07315100
What this trial is testing

Navigated Partial Nephrectomy

Who this might be right for
Renal CancerPartial Nephrectomy
The Netherlands Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05072600
What this trial is testing

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder NeoplasmsBladder Tumors+2 more
Peking University First Hospital 54
Large-scale testing (Phase 3)Study completedNCT03474107
What this trial is testing

Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Who this might be right for
Ureteral CancerUrothelial CancerBladder Cancer
Astellas Pharma Global Development, Inc. 608
Testing effectiveness (Phase 2)Study completedNCT00678119
What this trial is testing

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Who this might be right for
Renal Cell Carcinoma
Argos Therapeutics 25
Not applicableUnknownNCT05018429
What this trial is testing

Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 100
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Not applicableActive Not RecruitingNCT06350734
What this trial is testing

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Who this might be right for
Stage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+2 more
Mayo Clinic 204
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Not applicableStudy completedNCT05410509
What this trial is testing

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Who this might be right for
Renal Cell Carcinoma (RCC)
University of Alabama at Birmingham 25
Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT00073112
What this trial is testing

ABT-751 in Patients With Renal Cell Cancer

Who this might be right for
Renal Cell Cancer
Abbott 60
Not applicableStudy completedNCT04055311
What this trial is testing

Recovery Support for Bladder Cancer Patients and Caregivers

Who this might be right for
Bladder CancerPatient EngagementPatient Empowerment+1 more
Northwell Health 174
Next Page